Superwellness Program: a cognitive-behavioral therapy-based group intervention to reduce weight gain in patients treated with antipsychotic drugs

• Published in: Revista brasileira de psiquiatria 2017-07, Vol.39 (3), p.244-251
• Main Authors: Magni, Laura R, Ferrari, Clarissa, Rossi, Giuseppe, Staffieri, Elena, Uberti, Aldo, Lamonaca, Dario, Boggian, Ileana, Merlin, Silvia, Primerano, Giuseppe, Mombrini, Alessandra, Poli, Roberto, Saviotti, Francesco M, Caldera, Maria T, Zanotti, Luciana, Rossi, Roberta
• Format: Article
• Language: English
• Subjects: Adult; Aged; Antipsychotic; Antipsychotic Agents - adverse effects; Body Mass Index; Cognitive Behavioral Therapy - methods; cognitive-behavioral therapy; Female; Follow-Up Studies; Health Promotion - methods; Humans; Male; Middle Aged; obesity; Obesity - etiology; Obesity - therapy; Original; Prospective Studies; PSYCHIATRY; Psychotherapy, Group - methods; Schizophrenia - therapy; weight gain; Weight Reduction Programs - methods
• ISSN: 1516-4446; 1809-452X; 1809-452X
• DOI: 10.1590/1516-4446-2016-1993

To assess the effectiveness of a cognitive-behavioral therapy-based intervention (Superwellness Program) on weight gain compared with a treatment-as-usual (TAU) approach in patients treated with antipsychotics, and to evaluate the relationship between body mass index (BMI) variation and clinical variables. Eighty-five patients treated with antipsychotics were allocated across two groups, experimental (n=59) and control (n=26). The Superwellness Program (experimental group) consisted of 32 twice-weekly 1-hour sessions, conducted by a psychologist and a nutritionist/nurse, concurrently with moderate food intake and moderate physical activity plans. Sociodemographic, clinical, and biological variables were collected at baseline, at the end of intervention (16 weeks), and after 6 months. BMI change from baseline differed significantly between the experimental and control groups, with a larger decrease in the experimental group (F = 5.5, p = 0.021). Duration of illness moderated the effect of treatment on BMI (p = 0.026). No significant (p = 0.499) effect of intervention during the follow-up period was found. Interestingly, the intervention indirectly induced a significant (p = 0.024) reduction in metabolic risk by reducing BMI. A cognitive-behavioral therapy-based intervention could be useful in reducing weight in a clinical population taking antipsychotics, with consequent benefit to physical and mental health.